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ABSTRACT:  249 words (max 250) 
 
OBJECTIVE – Previous animal studies suggest a functional relationship between 
metabolism, type 2 diabetes and the amplitude of daily rhythms in white adipose 
tissue (WAT).  However, data interpretation is confounded by differences in genetic 
background and diet, or limited sampling points.  We have taken the novel approach 
of analysing serial human WAT biopsies across a 24-hour cycle, in controlled 
laboratory conditions. 
 
RESEARCH DESIGN AND METHODS – Lean (n = 8), overweight/obese (n = 
11), or overweight/obese with type 2 diabetes (n = 8) volunteers followed a strict 
sleep-wake and dietary regime for 1 week prior to the laboratory study.  They were 
then maintained in controlled light-dark conditions, semi-recumbent posture and fed 
hourly during wake periods.  Subcutaneous WAT biopsies were collected 6-hourly 
over 24-hours and gene expression was measured by quantitative PCR. 
 
RESULTS – Lean individuals exhibited significant (P < 0.05) temporal changes of 
core clock (PER1, PER2, PER3, CRY2, BMAL1, DBP) and metabolic (REVERBα, 
RIP140, PGC1α) genes.  The BMAL1 rhythm was in approximate antiphase with the 
other clock genes.  Surprisingly, there was no significant effect (P > 0.05) of 
increased body weight or type 2 diabetes on rhythmic gene expression. 
 
CONCLUSIONS – The robust nature of these rhythms and their relative phasing 
indicate that WAT can now be considered as a peripheral tissue suitable for the study 
of in vivo human rhythms.  Comparison of data between subject groups clearly 
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indicates that obesity and type 2 diabetes are not related to the amplitude of rhythmic 
WAT gene expression in humans maintained under controlled conditions. 
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INTRODUCTION 
 
Circadian clocks regulate daily changes in a wide range of physiological and 
behavioural functions, including the timing of sleep. Disruption of circadian biology 
or sleep has profound metabolic consequences (1), which have lead to the 
development of a major research effort to understand the links between these 
processes.  By understanding the temporal regulation of metabolic physiology, it is 
anticipated that common behaviours and clinical interventions can be optimised to 
reduce the impact of modern society on the incidence of metabolic diseases, such as 
diabetes. 
 
There are clear links between circadian clocks and metabolism.  In mouse models, 
transgenic disruption of key clock-related genes induces marked metabolic 
phenotypes (2-5).  In humans, chronic desynchrony of internal circadian time with the 
external environment (e.g. during shift work) correlates with increased incidence of 
obesity, type 2 diabetes and cardio-metabolic diseases (6).  Moreover, consistent with 
the transgenic mouse data, recent work has linked polymorphisms of human circadian 
clock genes with metabolic dysfunction (7-9). 
 
The mammalian circadian timing system consists of a ‘master’ clock within the 
suprachiasmatic nuclei (SCN) of the hypothalamus and a series of ‘peripheral’ clocks, 
which are located in extra-SCN regions of the brain as well as in almost all other 
tissues (10).  The environmental light-dark cycle synchronises the circadian system by 
acting through the SCN clock, which then maintains temporal order of the peripheral 
clocks via multiple rhythmic outputs (10).  These SCN-driven pathways include 
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neuronal (e.g. sympathetic tone), endocrine (e.g. melatonin and cortisol secretion) and 
behavioural (e.g. feeding) activity. 
 
Murine white adipose tissue (WAT), as with many other tissues, contains endogenous 
circadian timing properties (11,12) and approximately 10-20% of the murine WAT 
transcriptome is estimated to exhibit 24-hour variation (13,14).  Importantly, mice that 
are genetically susceptible to obesity and type 2 diabetes (15) or fed a high fat diet 
(16) exhibit reduced amplitude rhythms of gene expression in WAT, leading to the 
hypothesis that the robustness of WAT clocks is functionally associated with 
metabolic phenotype. 
 
This hypothesis has not been rigorously tested in humans.  The principal reason for 
this important gap in our knowledge stems from the difficulty in obtaining multiple 
serial biopsies of tissue from human volunteers.  To date, the literature on rhythmic 
gene expression in human WAT has primarily relied on either analysis of single time 
point biopsies maintained in culture (17), or the relative expression of genes at a 
single time point (18,19).  Clearly neither of these methods is ideal for the assessment 
of in vivo 24-hour rhythms. 
 
In this study, serial human biopsies across a 24-hour cycle have been analysed using a 
carefully controlled protocol designed to minimise the effect of confounding factors 
on rhythmic physiology.  We have studied 3 defined groups of human volunteers to 
investigate daily WAT rhythms; lean individuals have been compared with subjects 
who are overweight/obese or overweight/obese with type 2 diabetes. 
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RESEARCH DESIGN AND METHODS 
 
All aspects of the study were conducted in accordance with the Declaration of 
Helsinki and received a favourable ethical opinion from the Surrey Research Ethics 
Committee and the University of Surrey Ethics Committee. 
 
Participants.  Volunteers completed questionnaires to assess general health and 
ensure normal sleep and diurnal preference.  They then attended a pre-screening 
session at the University of Surrey, typically within 1 month of the laboratory session 
and during the early afternoon.  Body mass index (BMI, m2/kg), waist circumference 
were measured; fasting blood samples were provided for measurement of plasma 
HbA1c, insulin and glucose concentration, and homeostatic model assessment of 
insulin resistance (HOMA-IR; calculated using HOMA Calculator v2.2 software, 
Diabetes Trial Unit, University of Oxford, UK). 
 
27 male volunteers were recruited; 8 lean, 11 overweight and 8 overweight with type 
2 diabetes.  Of the patients with type 2 diabetes, average time since diagnosis was 6.9 
± 2.3 years; 3 were controlled by diet and exercise; the other 5 patients were treated 
with combinations of metformin, statins, ramipril and lisinopril.  One participant 
within the lean group was a smoker, and was required to refrain from smoking for one 
week prior to the study.  None of the participants had undertaken shift work within 5 
years of the study, nor crossed any time zones within one month of the study. 
 
For 1 week prior to the laboratory study, volunteers were required to maintain 
prescribed daily feeding times and sleep-activity (sleep 22:30-06:30), which were 
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monitored using wrist actigraphy (AWL, Cambridge Neurotechnology, Cambridge 
UK), sleep diaries, food diaries and recorded messages on a laboratory time-stamped 
answer phone.  Participants were also required to refrain from eating fatty or sugary 
foods and drinking alcohol or caffeine throughout the week.  For the final three days 
of this baseline week, food was provided by the research team, to enable control of 
timed behaviour, together with both the quantity and quality of nutrient intake.  
During these three days, the daily caloric content of the supplied food was basal 
metabolic rate x 1.5 with approximately 35% of energy from fat. 
 
Laboratory study.  All experimental procedures were carried out at the Surrey 
Clinical Research Centre.  Volunteers arrived in the afternoon of day 0 for a night of 
adaptation.  Throughout the 2-day study, they were required to maintain a semi-
recumbent posture.  They were required to remain awake with lights-on between 
06:30-22:30 (440-825 lux in direction of gaze) and allowed to sleep with lights-off 
between 22:30-06:30 (0 lux).  During the waking period, participants were fed with 
hourly nutritional drinks (Fortisip; Nutricia, Schiphol, Netherlands) and were allowed 
to drink water ad libitum.  Daily energy intake was basal metabolic rate x 1.1, divided 
equally over the waking hours. 
 
Four subcutaneous WAT biopsies were taken under local anaesthetic (lidocaine) from 
four different sites of the upper buttock region of each participant at 6-hourly intervals 
for 24-hours, beginning at 10:30 on day 1.  The sampling order of the four biopsy 
sites was randomised between groups and subjects.  This WAT depot is known to 
exhibit metabolic activity (20). 
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Analysis of gene expression.  WAT biopsies were washed with saline and snap-
frozen in liquid nitrogen before storage at -800C.  Total RNA was extracted using 
TRIZOL, according to the manufacturer’s instructions.  cDNA was synthesised and 
expression was measured for genes integral to the circadian clock (PER1, PER2, 
PER3, CRY2, BMAL1, DBP) and involved in metabolic activity (REVERBα, RIP140, 
PGC1α) by quantitative Taqman real-time PCR as described previously (21).  Primer-
probe sets were designed in-house using Primer Express software (Table 1).  Standard 
curves (R2 > 0.99) were generated using human genomic DNA (Promega Corporation, 
Southampton, UK) and expression of all genes was normalised to GAPDH, as in 
previous studies of adipose clock gene expression (15,16). 
 
Statistical analysis.  Pre-screen data were analysed using 1-way ANOVA with Tukey 
post-hoc test.  Correlation analyses were conducted using linear regression, and the 
gene expression time course from biopsies was performed using 1-way or 2-way 
repeated measures ANOVA (factors time and group) with Tukey post-hoc test. 
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RESULTS 
 
Pre-screen data are shown in Table 2.  Despite efforts to age-match the participants, 
there was a significant (P < 0.05) difference in age, with post-hoc analysis revealing a 
significant difference only between the overweight and type 2 diabetes groups.  
However, subsequent analysis using age as a co-variant revealed that age per se did 
not alter gene expression (data not shown).  There were significant (P < 0.05) 
differences in BMI, waist circumference, fasting plasma glucose and insulin 
concentrations, HbA1c levels and HOMA-IR, with highest values occurring in 
participants with type 2 diabetes.  There was no significant difference in plasma 
insulin, glucose, HbA1c or HOMA-IR between lean and overweight/obese groups, 
indicating that our overweight/obese participants were insulin-sensitive. 
 
In lean individuals, there was a significant (P < 0.05) effect of time on the expression 
of multiple genes involved in circadian (PER1, PER2, PER3, CRY2, BMAL1, DBP) 
and metabolic functions (REVERBα, RIP140, PGC1α) (Fig. 1).  Minimum expression 
of REVERBα and DBP occurred around the middle to end of the afternoon.  In 
keeping with circadian gene expression in other tissues (10), the phase of PER1, 
PER2, PER3 and CRY2 was slightly delayed compared to REVERBα and DBP, with 
minimum expression occurring around the evening light-dark transition.  The BMAL1 
rhythm was in approximate antiphase to the other circadian genes, with maximal 
expression around the evening light-dark transition. 
 
Analysis by 2-way repeated measures ANOVA of the data from all of the 
experimental groups confirmed a significant (P < 0.05) effect of time on gene 
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expression (Fig. 2).  However, surprisingly, we did not observe a significant effect of 
experimental group on the expression of any gene.   The only gene to exhibit a 
significant (P < 0.01) time x group interaction was BMAL1.  Tukey post-hoc analysis 
revealed that BMAL1 expression 16.5 hours after lights-on (equivalent to clock time 
23:00) was significantly (P < 0.05) lower in the overweight/obese participants than in 
the lean or type 2 diabetic groups. 
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DISCUSSION 
 
Consistent with a previous study (22), our data reveal robust diurnal rhythmicity 
within human WAT in vivo.  To date, limited data have been published concerning 
clock gene expression in this tissue.  Due to difficulties in acquiring human tissue, 
some studies have measured clock gene expression in WAT collected at a single time 
point (18,19), although it is clearly difficult to infer rhythmical changes from such a 
temporally limited data set.  An elegant compromise has been to culture explants of 
tissue taken at a single time point and then measure gene expression in fragments of 
the biopsies over a 24-hour time course (17).  Although such studies highlight 
endogenous WAT rhythms, they do not reflect gene expression in vivo.  We therefore 
measured gene expression in human tissue explants harvested across a whole 24-hour 
cycle to provide in vivo human WAT rhythms. 
 
Animal models suggest that obesity and type 2 diabetes reduce rhythm amplitude in 
murine WAT, as lean C57BL/6J mice exhibit higher amplitude WAT rhythms than 
obese/diabetic KK and KK-Ay mice (15).  Other data revealed reduced amplitude 
rhythms in mice that have become obese due to a high-fat diet (16).  However, Ando 
et al (15) compared mice with differing genetic backgrounds, which complicate 
interpretation of their data, and it is possible that dietary intervention could directly 
regulate gene expression rather than obesity per se. 
 
In contrast to the above studies, we observed minimal differences between clock gene 
rhythms in human WAT.  Interpretation of the minor difference in BMAL1 expression 
is not clear; although mouse Bmal1 has been implicated in the control of adipogenesis 
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in vitro (23), juvenile Bmal1-/- mice develop adipose depots comparably to their wild 
type litter mates (24).  Furthermore, the similarity between gene expression profiles in 
lean individuals and those overweight with type 2 diabetes suggests that BMI is not 
the cause of the time x group interaction for BMAL1 in the overweight, non-diabetic 
individuals. 
 
The similarity of gene expression profiles between our experimental groups may 
partly result from a lack of extreme phenotypic differences.  Although there was not a 
large disparity in BMI between our groups, all participants fell into the current clinical 
guidelines for lean/healthy, obese and type 2 diabetic individuals.  There was 
therefore no effect of obesity or type 2 diabetes per se on human WAT rhythmicity.  
It remains possible that severely obese individuals may exhibit reduced amplitude 
WAT rhythmicity; however, interpretation of data from such individuals is 
complicated by various confounding factors, such as co-morbidities associated with 
type 2 diabetes. 
 
Another difference between our study and previous work (25) is the high level of 
glycaemic control in our participants.  We specifically aimed to investigate the 
relationship between WAT rhythmicity, body weight and presence of type 2 diabetes.  
We therefore eliminated as many additional factors as possible.  Diurnal adipose gene 
expression may be modulated by the level of glycaemic control and/or drugs taken by 
diabetic individuals.  Alternatively, the association between metabolic state and WAT 
rhythmicity might vary between adipose depots.  However, due to limitations of 
sampling and experimental group size, we could not directly address these 
possibilities in the current study. 
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 The persistence of 24-hour rhythms in WAT from patients with type 2 diabetes now 
suggests that the link between human circadian and metabolic physiology occurs 
outside of WAT, at least in the earlier stages of the disease. 
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TABLE 1.  TaqMan PCR primer-probe sets. 
Gene Upper 
Primer (5’ to 
3’ end) 
Lower 
Primer (5’ to 
3’ end) 
TaqMan 
probe (5’ 
to 3’) 
GenBank 
Accession 
Number 
Region 
amplifie
d (bp) 
Produc
t size 
(bp) 
PER1 CCCTTTGG
TGACCCCA
ATG 
GCCCCATA
AGGATAG
CTGGAT 
TGGCCT
TGGTGC
TCCCTA
ACTATC
TGTTC 
NM_002616 2974 - 
3051 
78 
PER2 GTCCAGCC
CCCACCTT
TC 
GGGAAGG
AATAACTG
GGTAGCA 
CTGCCC
CTTTGG
CGCCTG
TCAT 
NM_022817 2908 - 
2978 
71 
PER3 CCTGGACC
CTGAACAT
GCA 
TGTGAGCC
CCACGTGT
TTAA 
CCAGCC
CCTTTG
ACCTCG
GAAGA 
NM_016831 2136 - 
2200 
65 
CRY2 AGTGGGCT
GAGGGCAA
GAC 
CAGCCCTC
CTGCCTCA
GTT 
TTCCCTT
GGATTG
ATGCCA
TCATGA
CC 
NM_021117 1128 - 
1197 
70 
DBP CGTGGAGG
TGTTGATG
ACCTT 
TCGTGGCC
AGGAATG
CTT 
AACCCG
ACCCAG
CTGATC
TTGCC 
NM_001352 982 - 
1050 
69 
BMAL1 TGCCTCGT
CGCAATTG
G 
ACCCTGAT
TTCCCCGT
TCA 
CGACTG
CATTCT
CATGTA
GTTCCA
CAACCA 
NM_001178 1342 - 
1409 
68 
REVERBα CTTCAATG
CCAACCAT
GCAT 
CCTGATTT
TCCCAGCG
ATGT 
AGGTAG
CCCTCC
AGCCAC
CACCC 
NM_021724 1565 - 
1629 
65 
RIP140 GGCAAACA
GGATAGCA
CATTACTG 
CCTGATTT
GTTGTGAC
AGAGCAA 
TTTGCTT
CAGTCA
TTCAGC
TCTAGG
CTGCA 
NM_003489 974-
1060 
87 
PGC1α CCTGCTCG
GAGCTTCT
CAAAT 
TTTCTGTT
CTCTGTGG
GTTTGGT 
TCTGAC
CACAAA
CGATGA
CCCTCC
TCA 
NM_013261    737-809 73 
GAPDH CAAGGTCA
TCCATGAC
AACTTTG 
GGGCCATC
CACAGTCT
TCTG 
ACCACA
GTCCAT
GCCATC
ACTGCC
A 
NM_002046 585-674 90 
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TABLE 2.  Participant pre-laboratory data. 
 
Variable Lean Overweight/Obese Type 2 Diabetic 
N 8 11 8 
Age (years) 53.6 ± 6.0 49.9 ± 7.5 58.0 ± 4.5 # 
BMI (kg/m2) 23.2 ± 1.4 30.2 ± 2.3 * 31.2 ± 3.2 * 
Waist circumference (cm) 88.9 ± 6.5 105 ± 4.3 * 110.9 ± 10.6 * 
Fasting glucose (mM) 4.2 ± 0.7 4.8 ± 0.7 6.7 ± 1.3 *# 
Fasting insulin (pM) 28.1 ± 16.8 39.2 ± 17.4 93.6 ± 78.7 *# 
HbA1c (mM) 5.4 ± 0.4 5.4 ± 0.5 6.8 ± 0.8 *# 
HOMA-IR 0.5 ± 0.1 0.7 ± 0.1 1.9 ± 0.5 *# 
 
Data are presented as mean ± SEM.  * P < 0.05 vs Lean group; # P < 0.05 vs 
Overweight/Obese group.  HOMA-IR, homeostatic model assessment of insulin 
resistance. 
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FIGURE LEGENDS 
 
FIG. 1.  Robust 24-hour changes of gene expression in human WAT from lean 
individuals.  Data are presented as mean ± SEM of n = 8-11 values, normalised to 
GAPDH.  There was a significant effect of time (P < 0.05, 1-way repeated measures 
ANOVA) on the expression of each gene.  Horizontal bars represent wake (white) and 
sleep (black) periods during the laboratory study.  Zeitgeber time 0 represents the time 
of lights-on (equivalent to clock time 06:30).  
 
FIG. 2.  Comparison of 24-hour gene expression profiles in human WAT from 
individuals who are lean (solid line, diamonds), overweight/obese (dashed line, 
squares) or overweight/obese with type 2 diabetes (dotted line, triangles).  Data are 
presented as mean ± SEM of n = 8-11 values, normalised to GAPDH.  For all genes, 
there was a significant (P < 0.05) effect of time but no subject group effect on gene 
expression (2-way repeated measures ANOVA).  With the exception of BMAL1 (P < 
0.01), there was no significant interaction between time and subject group on gene 
expression.  Horizontal bars represent wake (white) and sleep (black) periods during 
the laboratory study.  Zeitgeber time 0 represents the time of lights-on (equivalent to 
clock time 06:30). 
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